News
Action News anchor Vanessa Vasconcelos sat down with Emergency Physician Doctor Rais Vohra to talk about viruses like the Flu ...
The monoclonal antibody nirsevimab, designed to mimic natural antibodies, significantly reduces severe RSV-related ...
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial ...
Germany's Robert Koch Institute (RKI) for infectious diseases has declared the country's RSV wave officially over. RSV, or ...
ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.
HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results